The Japanese pharma has been building a presence in oncology over the last few years through products such as its Adcetris (brentuximab vedotin), and its $5.2 billion acquisition of Ariad at the ...
At ARIAD Psychological Services, Dr. Adodo brings a wealth of experience in conducting comprehensive neuropsychological and psychological evaluations. These evaluations serve as the bedrock in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback